RNAi could protect experimental animals from Foot-and-mouth disease virus (FMDV), but pivotal issue is delivery of RNAi. In this study, shRNA recombinant lentiviral plasmid RNAi-LT6 targeting VP1 of FMDV, which strongly suppressed the transient expression of a FLAG-tagged VP1 protein in 293T cells and significantly inhibited viral replication in BHK-21 cells, was screened and transfected into bovine fetal fibroblast cells. With subsequent somatic cell cloning, three 4-month-old transgenic fetuses were obtained, and integration into chromosome and expression of shRNA in primary transgenic tongue epithelium cells were confirmed by Southern hybridization and Northern assay, respectively. shRNA significantly suppressed viral RNA synthesis and viral replication in primary transgenic tongue epithelium cells after inoculation of 200 TCID 50 of FMDV. The results suggested that transgenic cloning may be a useful tool for RNAi delivery and RNAi anti-viral strategy, and RNAi-LT6 could be a candidate shRNA used for preparation of transgenic cattle against FMDV.
Introduction
Foot-and-mouth disease virus (FMDV), the prototype member of the Aphthovirus genus, is a single-stranded, positive-sense RNA genome virus, which causes Foot-and-mouth disease (FMD) of many cloven-hoofed animals, including cattle, swine, and sheep. The disease causes substantial lost of milk in dairy cattle and reduction in the growth rate of meat animals. The way of its control in an enzootic area is strict vaccination and restricted animal movement (Balamurugan et al., 2004) . The killed FMD vaccine has been successfully used to reduce the number of disease outbreaks in many parts of the world where the disease is enzootic. Although protective immune responses against FMDV can be helpful, the viral rapid replication and spread could exceed development of immune defense and surmount the immune system. At the same time, FMDV can also evade innate immune responses through its ability to shut down cellular protein synthesis (Summerfield et al., 2009) , and interrupt the innate immune response via evolving mechanisms to break off the normal function of dendritic cells and natural killer cells (Golde et al., 2008) . In addition, antigenic diversity and continuous co-circulation of different serotypes in a given geographical region and persistence of virus in infected or vaccinated animals make the disease very difficult to control (Balamurugan et al., 2004) . Therefore, novel antiviral control approaches are being developed and tested, and integrated FMD control strategies are being designed in an effort to eliminate or more effectively control FMD worldwide.
RNA interference (RNAi) using short hairpin RNA (shRNA) is an antiviral approach that could be used to protect either animal species (Bitko and Barik, 2001; Gitlin et al., 2002) or plants (Waterhouse et al., 2001 ) from viruses. shRNAs are highly specific tools to silence gene expression (Leonard and Schaffer, 2006) and have been widely used to inhibit FMDV in vitro and/or in vivo (Chen et al., 2004 (Chen et al., , 2006 Cong et al., 2010a; de los Santos et al., 2005; Joyappa et al., 2009; Kahana et al., 2004; Liu et al., 2005; Lv et al., 2009; Wang et al., 2012) . However, pivotal issues of RNAi therapeutics are delivery, specificity and stability of the RNAi reagents. Of these, delivery is currently considered the biggest hurdle (Perrimon et al., 2010) . In fact, transgenic mice with shRNA targeting FMDV were generated, and showed much less susceptible to the challenge of FMDV as compared to the control mice (Wang et al., 2010) . However, no studies of transgenic shRNA targeting FMDV in cloven-hoofed animals have been reported. Whereas expression of lysostaphin in bovine mammary combated mastitis and protected transgenic cattle from the challenges of Staphylococcus aureus in mammary gland (Donovan et al., 2005; Kerr and Wellnitz, 2003; Wall et al., 2005) . Therefore, it is possible to address disease problems in agriculturally important species using transgenic technology (Donovan et al, 2005) , and genetic engineering can provide a viable tool for enhancing resistance to disease and improve the wellbeing of livestock. In this study, RNAi-LT4, RNAi-LT5 and RNAi-LT6 targeting VP1 gene were synthesized as small hairpin RNA (shRNA) and constructed into Lenti-virus plasmid. All shRNAs could partly or significantly silence VP1 gene in 293T cells and suppressed replication of FMDV in BHK-21 cells. RNAi-LT6 recombinant Lenti-virus plasmid was then transfected into bovine fetal fibroblast cells, with subsequent somatic cell cloning, three transgenic bovine fetuses stably expressing shRNA were obtained, and their primary tongue epithelium cells were used to evaluate potential anti-viral capability of shRNA after the challenge of FMDV.
Results

shRNAs inhibiting transient expression of VP1 in 293T cells
Three lentiviral shRNAs targeting VP1 of FMDV type Asia 1, RNAi-LT4, RNAi-LT5 and RNAi-LT6, were constructed. pcDNA3-FLAG-VP1 plasmid was co-transfected into 293T cells, along with each shRNA recombinant lentiviral vectors. Expression of FLAG-VP1 protein was determined by Western Blotting. As shown in Fig. 1A , all shRNAs targeting VP1 significantly inhibited transient expression of FLAG-VP1 as compared to LacZ shRNA control. RNAi-LT6 almost completely eliminated expression of VP1. These results strongly suggested a direct role of shRNAs in specifically blocking transient expression of VP1 protein in 293T cells.
shRNA silencing viral VP1 gene and inhibiting FMDV replication in BHK-21 cells
We next determined whether shRNAs could block natural expression of viral VP1 gene and inhibit FMDV replication. The BHK-21 cell lines stably expressing shRNAs were sorted by fluorescence-activated cell sorter (FACS) analysis based on shRNA recombinant H1 lentiviral plasmids encoding eGFP. The stable cell clones were inoculated with 200 TCID 50 of the FMDV strain, VP1 mRNA expression and viral titers were determined. As shown in Fig. 1B , VP1 mRNA expression was inhibited by all shRNAs, and strongly degraded by RNAi-LT6 as compared to control shRNA (LacZ). b-actin mRNA expression by contrast was not altered by either shRNA. By TCID 50 Assay, RNAi-LT4 inhibited over 60% of viral replication as compared to LacZ control, while RNAi-LT5 showed more than 84% inhibition of viral replication, and RNAi-LT6 inhibited over 95% of viral replication (Fig. 1C) . Thus, RNAi-LT6 specifically and significantly targeted VP1 mRNA and reduced viral replication in vitro.
Development of reconstructed shRNA transgenic embryos shRNA recombinant lentiviral plasmid RNAi-LT6 was then transfected into bovine fetal fibroblast cells. 14 days later, transgenic bovine fetal fibroblast cell clones were selected based on eGFP expression, and shRNA positive transgenic cell clones were confirmed by PCR and sequencing. After shRNA transgenic cells from a same cell clone were transferred into enucleated oocyte cytoplasts, total of 216 reconstructed oocytes were obtained based on eGFP expression. The fusion, cleavage and blastocyst development rates were 83.8% (181/216), 82.3% (149/ 181), and 30.2% (45/149), respectively. Forty-two blastocysts were finally screened based on their development, and then transferred to 21 synchronized recipient cows. Pregnancy rates at 60 days were 38.1% (8/21). Since the major focus of this study is to evaluate the efficiency of FMDV shRNA targeting after transgenic delivery, three 4-month-old cloning fetuses were obtained after pregnancy for 4 months, instead of adult animals, for the sake of saving time and money.
shRNA integration into chromosome of cloned bovine fetuses and expression in primary transgenic tongue epithelium cells
The expected shRNA fragments could be amplified from the genomic DNA of cloned fetuses, but not from normal fetus, as shown in Fig. 2A , and then confirmed by DNA sequencing. Furthermore, the shRNA integration into chromosome of cloned fetuses and expression in primary transgenic tongue epithelium cells were confirmed by Southern Blotting and Northern, respectively, whereas there was no expected band detected in normal fetus or cells ( Fig. 2B and C). Thus, shRNA was indeed integrated into chromosome and expression in tongue epithelium cells of transgenic bovine fetuses.
RNAi-mediated degradation of viral RNA in primary transgenic bovine tongue epithelium cells
The primary tongue epithelium cells were inoculated with 200 TCID 50 , and viral samples were taken at designated time points and viral RNA was determined by real-time RT-PCR. The representive result of three independent experiments was shown as in Fig. 3A , there was significant difference in relative amounts of viral RNA between cells from three transgenic (T1, T2, and T3) and normal fetuses (N1, N2, and N3). The average viral RNA in transgenic cells were 1.9 Â 10 3 and 2.7 Â 10 4 at 24 and 48 h, respectively, as compared to 2.4 Â 10 4 and 2.7 Â 10 5 in normal cells ( Fig. 3B ). So shRNAs expression in transgenic cells inhibited 91.9% and 90.1% of viral RNA replication as compared to normal control cells (Fig. 3C ). Thus, transgenic shRNAs in primary transgenic tongue epithelium cells significantly degraded viral RNA.
RNAi-mediated protection of primary transgenic bovine tongue epithelium cells from FMDV infection
Viral replications were determined, as shown in Fig. 4A , although there was no difference in viral titer among cells expressing three transgenic shRNA (T1, T2, and T3), or among corresponding normal controls (N1, N2, and N3), significance exists when transgenic cells were compared to the normal controls. The average viral titers in three normal primary bovine fetus tongue epithelium cells were about 9.6 Â 10 5 and 7.2 Â 10 6 TCID 50 at 24 and 48 h, respectively, whereas the average titers in transgenic cells were 3.7 Â 10 4 and 5.1 Â 10 5 TCID 50 , respectively ( Fig. 4B) . Therefore, the shRNAs expression in transgenic cells inhibited about 96.15% or 92.88% of viral replication (Fig. 4C ). We concluded from this study that, expression of shRNAs targeting VP1 gene in primary transgenic bovine tongue epithelium cells significantly blocked viral replication.
Discussion
RNAi silencing variant viral genes could protect cells and/or experimental animals from challenge of FMDV, and the protection or prevention was specific and effective. Subcutaneous injection of a multiple targeting RNAi plasmid against VP1 gene in the neck caused suckling mice significantly less sensitive to different serotypes of FMDV (Chen et al., 2004; Cong et al., 2010a) ; recombinant shRNA plasmids, which silenced 3D gene, protected guinea pigs (Joyappa et al., 2009) or swine (Chen et al., 2006 ) from FMDV; An attenuated Salmonella choleraesuis-mediated siRNA targeting 3D gene protected guinea pigs and swine from virus (Cong et al., 2010b) ; shRNA against VP4 protected bovine epithelium cells from virus (Wang et al., 2012) . RNAi has been becoming an effective antiviral strategy for its specific silencing of viral gene expression and could be a viable approach to control FMD (Chen et al., 2006; Joyappa et al., 2009 ). However, major issues of RNAi for prevention of viral infection are delivery, specificity and stability of the RNAi reagents, delivery is the biggest problem (Perrimon et al., 2010) . shRNA targeting FMDV expressed in transgenic mice could inhibit viral replication and protect transgenic animals from virus after challenge of FMDV (Wang et al., 2010) . Therefore, production of transgenic animals may be a useful strategy for RNAi against FMDV.
In this study, the three shRNAs, which targeted sequences of VP1 gene of ASIA1/YS/CHA/05 strain, were screened for inhibition of transient expression of a FLAG-VP1 protein in 293T cells at first (Fig. 1A) . Moreover, RNAi-LT6 strongly blocked mRNA expression of VP1 gene, and inhibited viral replication by more than 95% in BHK-21 cells stably expressing shRNA (Fig. 1B and C) . A very high level of inhibition of virus replication may be due to selection of stable clone of BHK-21 cells in which most cells expressed targeting shRNAs. The transient transfection of RNAi expressing plasmids/siRNA into BHK-21 cells was a common delivery method (Chen et al., 2004 (Chen et al., , 2006 Cong et al., 2010a Cong et al., , 2010b Joyappa et al., 2009) , with limitation of transfection efficiency, shRNA/siRNA was not expressed in most cells, resulting in a reduced inhibition of viral replication.
Transgenic cells with RNAi-LT6 from a single donor cell clone were then transferred into enucleated oocyte cytoplasts, reconstructed embryos were selected based on their expression of eGFP and transferred to synchronized recipient cows. Since evaluation of the efficiency of FMDV shRNA targeting after transgenic delivery is very important, if we use adult animals, it will take a long time and a large amount of money, so we selected 4-month-old fetuses, instead of adult animals, to prepare primary tongue epithelium cells as a model used for FMDV challenge assay in this study. Integration of shRNA into chromosome of transgenic fetuses and shRNA expression of primary transgenic bovine epithelium cells were confirmed by Southern hybridization and Northern at first, respectively, and then primary tongue epithelium cells of transgenic bovine fetuses were inoculated with 200 TCID 50 of FMDV. The shRNA expressed in transgenic fetuses could significantly degrade viral RNA at designated time points (Fig. 3) , and blocked viral replication (Fig. 4) , so primary transgenic bovine fetus tongue epithelium cells could significantly resist against challenge of FMDV. Norm Trans Fig. 4 . RNAi-mediated protection of primary transgenic bovine tongue epithelium cells from FMDV infection: the primary bovine tongue cells were isolated from three normal or three transgenic fetuses, cultured in 96-well plates and inoculated with 200 TCID 50 of the FMDV strain each well. Virus samples were collected at indicated time points, and virus titer was then determined. The viral titers in three normal (N1, N2, N3) or three transgenic (T1, T2, T3) cells from three independent experiments were presented as an average number of TCID 50 7 one standard deviation at different time (A), the average viral titers was compared between normal (Norm) and transgenic groups (Trans) (B), and viral inhibition by shRNA in transgenic cells was calculated as 1 À percentage of average number of TCID 50 of transgenic cells to that of normal controls (C). Duncan's multiple range test by SAS 8.0 system, means with the same letter are not significantly different (P 40.01).
The high speed of replication, short incubation time, and high contagiousness is the most important threat of FMDV virus. Therefore, although protective immune responses could be efficacious against FMDV, the rapidity of virus replication and spread can outpace immune defenses development and overrun the immune system (Summerfield et al., 2009) . In this study, shRNA inhibited over 90% of viral replication after FMDV challenge (Fig. 4) , not completely blocked viral replication, but significantly decrease the speed of viral replication. Therefore, it will be a useful strategy for transgenic cows to get more time to develop immune defense. Of course, whether transgenic cows indeed become resistant to FMDV infection will wait for the future study using adult transgenic cows upon FMDV challenge.
Due to their high degree of sequence specificity, shRNAs become ineffective in the presence of escape mutations within and outside the targeted regions (Westerhout et al., 2005) , and variations within multiple regions of the quasispecies of FMDV were retrospectively revealed by sequencing of FMDV genes. Thus, we need to screen much more effective shRNAs targeting FMDV using virus sensitive natural cells as a model, and it may be important to multiplex shRNAs in a single vector (Li et al., 2005) if RNAi is to be developed for therapeutic and preventive use.
In conclusion, we screened shRNA targeting viral VP1 gene, and confirmed its anti-viral function in primary tongue epithelium cells from transgenic fetuses expressing shRNA. This approach merits further investigation as a potential preventive strategy for FMD control in transgenic dairy cattle.
Materials and methods
Unless otherwise noted, all reagents used were obtained from Sigma Chemical Co. (St. Louis, MO, USA). All procedures were approved by the Shandong Academy of Agricultural Sciences Animal Care and Use Committee.
Cells
293T cells and BHK-21 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Primary bovine tongue epithelium cells were obtained as follows: small pieces from the mucosa of the tip of a bovine tongue were used as explants to initiate a cell culture with Iscove's Dulbecco modified Eagle medium (DMEM) and Ham's F12 medium at 1:1 supplemented with 10% fetal calf serum, and an outgrowth of polymorphic cells but mostly epithelium-like cell types was observed.
Titration of FMDV
BHK-21 cells or primary bovine tongue cells were passaged in 96-well plates with Iscove's Dulbecco modified Eagle medium (DMEM) and Ham's F12 medium at 1:1 supplemented with 10% fetal calf serum (FCS), and infected with 10-fold dilutions of FMDV ASIA1/YS/CHA/05 strain in four replicates per dilution when they developed a confluent monolayer. After 48 h, viral cytopathic effect (CPE) was monitored and 50% tissue infective dose (TCID 50 ) of virus was calculated using the Reed-Muench method.
Construction of shRNA recombinant lentiviral plasmids and VP1 recombinant pcDNA3
Lentivirus-based shRNA plasmids were constructed as described previously (Chen et al., 2011) 0 . The sequence of LacZ shRNA was not homologous to those of viral genes, so shRNA of LacZ recombinant lentivirus was negative shRNA control. These oliognucleotides were annealed to each other and ligated into H1 lentiviral plasmid, followed by DNA sequence confirmation. The PCR primer pair was LT1: 5 0 -TGT CGCTATGTGTTCTGGGA-3 0 and LT2: 5 0 -GGT ACA GTG CAG GGG AAA GA-3 0 . VP1 recombinant pcDNA3 plasmid was constructed. The PCR primer pair used for pcDNA3-Flag-VP1 was VP1-P1: 5 0 -GGG GTA CC G CCA CCA TGG ACT ACA AGG ACG ACG ATG ACA CTA CCA CCA CTG GCG AGT-3 0 and VP1-P2: 5 0 -GCT CTA GAT TAC TGT TTC TCA GGT GCA-3 0 ; PCR fragments were digested with Kpn I and Xba I, and subcloned into previously digested pcDNA3, followed by DNA sequence confirmation.
Co-transfection of lentiviral shRNAs and FLAG-tagged VP1 gene in 293T cells
Five microgram of pcDNA3-FLAG-VP1 was co-transfected into 293T cells with 5 mg of recombinant shRNA lentiviral plasmids, using Lipofectamine 2000, according to manufacturer's instruction (Invitrogen). After 48 h, transient expression of the FLAG-VP1 protein was determined by Western Blot, performed as described previously (He and Sun, 2007) . In brief, 293T cells were lysed using Lysis Buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Triton, 5 mM EGTA, 5 mM EDTA, 1 mM NaF, 1 mM Na 3 VO 4 , freshly added proteinase inhibitor tablet) and supernatants were collected by centrifugation. Proteins were separated on polyacrylamide gels in the presence of SDS and electrophoretically transferred onto nitrocellulose membrane. The membranes were blocked with 5% Blotto in TBS-T (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween-20) for 1 h at room temperature and probed with various antibodies against FLAG and b-actin (Sigma). 
Preparation of transgenic donor cells
Donor cell lines were established from a 50-days fetus of Holstein cow as described previously . Tissue was minced, suspended in DMEM/Ham's F12 (1:1) supplemented with 15% FBS and antibiotics, seeded in 25 cm 2 tissue culture flasks, and cultured at 37 1C in a humidified atmosphere of 5% CO 2 in air for several days. 10 mg of shRNA recombinant lentiviral plasmid RNAi-LT6 was transfected into bovine fetal fibroblast cells using Lipofectamine 2000 according to manufacturer's instruction (Invitrogen). After 48 h, the cells were sorted by fluorescenceactivated cell sorter (FACS) analysis based on eGFP co-expression in the viral plasmid, and subcultured in 96-well plate, about 0.7 cell per well. 14 days later, transgenic bovine fetal fibroblast cell clones were selected based on eGFP expression, and confirmed by PCR with primer pair LT1/LT2 and DNA sequencing.
Oocyte in vitro maturation (IVM)
Oocytes were maturated in vitro as described previously . Bovine ovaries were collected from a local abattoir and cumulus-enclosed oocyte complexes were aspirated from 3 to 8 mm follicles. Oocytes with evenly shaded cytoplasm and intact layers of cumulus cells were selected and cultured in maturation medium: M199 containing 10% fetal bovine serum (FBS; HyClone Laboratories, Logan, UT), 0.5 mg/ml FSH (Sioux Biochemicals, Sioux City, IA), 5 mg/ml LH (Sioux Biochemicals), 100 U/ml penicillin and 100 mg/ml streptomycin (HyClone Laboratories, Logan, UT) and cultured for 20 h prior to nuclear transfer.
Nuclear transfer
Routine manipulations were previously described . After maturation for 20 h, the cumulus cells were removed and oocytes with the first polar body were enucleated as cytoplast recipients. Single transfected cells were transferred to the perivitelline space of enucleated oocytes. The reconstructed couplets were fused in mannitol fusion buffer by two DC pulses of 1.8 kV/cm for 20 ms. Then the fused clones were activated by 5 mM ionomycin for 5 min and treated with 10 mg/ml cycloheximide in CR1aa medium for 5 h in 5% CO 2 in air at 38 1C. Following activation, the embryos were cultured in CR1aa medium supplemented with BSA for 40 h, then the cleaved embryos were transferred and cultured in CR1aa medium plus 4% FBS feeding with a single layer cumulus cells under 5% CO 2 in air at 38 1C with high humidity.
Embryo transfer
On day six or seven, compacted morulae and blastocysts were shipped overnight in equilibrated CR2 at 38.5 1C to the site of transfer. Two embryos were transferred nonsurgically to cows synchronized one day to the stage of embryonic development. Pregnancy was detected by transrectal ultrasound at embryonic days 60, and pregnant recipients were checked by ultrasound or palpation at approximately 30-days intervals to confirm ongoing pregnancies, and fetuses were obtained with surgery at four months.
shRNA integration into chromosome of cloned bovine fetuses
The genomic DNA from the ear tissue of 4-month-old cloned and normal fetuses were extracted according to standard molecule cloning instructions, and used as the template for PCR amplification with LT1/LT2 primer pair, then shRNA transgenic fragment (about 300 bp) was confirmed by DNA sequencing.
Up and Down primers of probe for Southern Blotting were designed according to the flanking sequence of shRNA in shRNA recombinant H1 Lenti-virus vector, Up primer 1: 5 0 -GAA GAA CGG CAT CAA GGT G-3 0 ; Down primer: 5 0 -TTG CTT CCC GTA TGG CTT-3 0 ; The shRNA recombinant H1 Lenti-virus vector was used for template to amplify 414 bp probe labeling with Invitrogen Platinum s Tag Kit. The genomic DNAs from the cloned and normal fetus were digested into smaller fragments with excess amounts of XhoI and ApaI for 18 h. The concentrated samples were hybridized with probe as standard protocol, and 3.6 kb of transgenic positive band was determined.
shRNA expression in primary bovine tongue epithelium cells Total RNA was isolated from the cells with TRIzol reagent (Promega). Ten microgram (mg) of total RNA were then size fragmented by electrophoresis on 1.5% agarose/formaldehyde gel, transferred onto Nitrocellulose membrane, prehybridized, and hybridized according to the method of Church and Gilbert (Church and Gilbert, 1984) . The cDNA was prepared with SuperScript. III First-Strand Synthesis System (invitrogen) from the total RNA using oligo dT primer. Up primer of bovine b-actin: probe was artificially synthesized as follows, sense chain: 5 0 -ACA GGA GAT CAT TGC ACC T-3 0 , anti-sense chain: 5 0 -AGG TGC AAT GAT CTC CTG T-3 0 , and then was annealing to double strain probe of shRNA. The complementary DNA probes were labeled with rediprimer TM II random primer labeling system (amersham) to yield a specific activity of 2-5 Â 10 8 cpm/mg, and used at a concentration of 10 6 cpm/ml hybridization solution. The final posthybridization wash was performed four times at 65 1C for 10 min each time with a solution containing 1% SDS, 1 mM EDTA, and 20 mM sodium phosphate, pH 7.2. The membranes were then exposed to X-ray film (Kodak) with intensifying screens at À 80 1C. For the reprobing, the original probe was removed by treating the membranes with boiling water for 10 min.
FMDV infection in primary bovine tongue epithelium cells 2 Â 10 5 of the primary normal or transgenic bovine tongue cells cultured in 12-well plates were inoculated with viruses at 200 TCID 50 (about 0.005 MOI) each well, after 1 h absorption, the medium was changed with fresh medium without FCS, and virus samples were collected at designated time points and frozen at À 80 1C until for assessment of FMDV titer and viral RNA. The viral RNA was isolated from virus sample using a TRIzol kit (Invitrogen), and cDNA was prepared with SuperScript III FirstStrand Synthesis System (invitrogen) and RT primers for viral RNA as follows, R1 5 0 -CTC TGT AGT CAC TGT CTG TC-3 0 , and oligo dT for bovine b-actin. The cDNA then was subjected to real-time RT-PCR analysis, according to the manufacturer's instruction of QuantiTect SYBR green RT-PCR kit (Qiagen). Cycling program was set as following: 95 1C for 10 min for the PCR initial activation and 40 cycles of denaturation at 95 1C for 15 s, annealing and extension at 60 1C for 1 min. PCR primer pair were used as follows, R1 and F1: 5 0 -CAA AAG ATG GTC ATG GGC-3 0 for viral RNA. The standard used was 10-fold dilutions of 10 7 TCID 50 of virus ml À 1 . All further computations were done using ABI Prism 7000 SDS Software (Applied Biosystems). The statistical analysis was based on data from three independent experiments.
